Für wen ist der Wettbewerb gedacht?

AZ, BY, BA, CZ, EE, KZ, KG, LT, LV, MD, PL, RU, GE, MN, TM, SK, SI, UA, UZ

Finanzielle Auszeichnungen

19 000 €

Internationale Bewertungskommission

Marina Maevskaya (RUS), Marek Hartleb (POL), Peter Jarčuška (SVK), Alexander Nersesov (KAZ), Yelena Zueva (UZB)

Siegreiche Arbeiten

1. Platz: Radan Brůha

Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis
Bruha R., Jachymova M., Petrtyl J., Dvorak K., Lenicek M., Urbanek P., Svestka T., Vitek L.

2. Platz: Petra Hiršová

Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes
Hirsova P., Ibrahim S. H., Krishnan A., Verma V. K., Bronk S. F., Werneburg N. W., Charlton M. R., Shah V. H., Malhi H., Gores G. J.

3. Platz: Piotr Eder

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
Eder P., Michalak M., Katulska K., Lykowska-Szuber L., Krela-Kazmierczak I., Stawczyk-Eder K., Klimczak K., Szymczak A., Linke K.

Die folgenden wissenschaftlichen Arbeiten rückten in die internationale Runde vor

First sleeve gastrectomy series in Azerbaijan
Bayramov N., Omarov T., Zeynalov N., Bayramli F.

Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis
Bruha R., Jachymova M., Petrtyl J., Dvorak K., Lenicek M., Urbanek P., Svestka T., Vitek L.

Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes
Hirsova P., Ibrahim S. H., Krishnan A., Verma V. K., Bronk S. F., Werneburg N. W., Charlton M. R., Shah V. H., Malhi H., Gores G. J.

Operations at alveococcosis liver lesion of the inferior vena cava and portal vein
Bebezov B. H., Umetaliev T. M, Mamashev N. Dj., Surov E. A., Esenkulov Ch. T.

The relationship of smoking, alcohol consumption, dental pathology and the prevalence of helicobacter pylori among ethnic groups in Kyrgyzstan
Dzhumbaev M. N., Dzhumanova R. G., Sabirov I. S.

New Combined Parameter of Liver and Splenic Stiffness as Determined by Elastography in Healthy Volunteers
Kassym L., Nounou M. A., Zhumadilova Z., Dajani A. I., Barkibayeva N., Myssayev A., Rakhypbekov T., Abuhammour A. M.

Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer
Kupcinskas J., Gyvyte U., Bruzaite I., Leja M., Kupcinskaite-Noreikiene R., Pauzas H., Tamelis A., Jonaitis L., Skieceviciene J., Kiudelis G.

Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasms
Blogowski W., Zuba-Surma E., Salata D., Budkowska M., Dolegowska B, Starzynska T.

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
Eder P., Michalak M., Katulska K., Lykowska-Szuber L., Krela-Kazmierczak I., Stawczyk-Eder K., Klimczak K., Szymczak A., Linke K.

Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Janczyk W., Lebensztejn D., Wierzbicka-Rucinska A., Mazur A., Neuhoff-Murawska J., Matusik P., Socha P.

The effect of proton pump inhibitors on the CYP2C19  enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine
Modak A. S., Klyarytska I., Kriviy V., Tsapyak T., Rabotyagova Y.

A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease
Shavrov A.,. Kharitonova A. Y, Davis E. M., Claggett B., Morozov D. A., Brown D. K., Shavrov A. A., Liu J. J.

Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis
Sheptulina A., Shirokova E., Nekrasova T., Blum H., Ivashkin V.

SPINK1 Promoter Variants in Chronic Pancreatitis
Hegyi E., Geisz A., Sahin-Toth M., Derikx M. M. H., Nemeth B. C., Balazs A., Hritz I., Izbeki F., Halasz A., Parniczky A., Takacs T., Kelemen D., Sarlos P., Hegyi P., Czako L.

Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy
Hlavaty T., Krajcovicova A., Letkovsky J., Sturdik I., Koller T., Toth J., Huorka M.

Consistent scheme of eradication therapy in peptic ulcer disease
Karimov M. M., Saatov Z. Z., Sobirova G. N.

Significance of IL28B Gene Polymorphism in the Prediction of Clinical Outcomes of Viral Hepatitis Leading to Liver Cirrhosis
Khikmatullaeva А. S., Ibadullaeva N. S.

The role of genetic factors in the development of liver cirrhosis in viral hepatitis B and D
Khikmatullaeva А. S., Musabaev E. I.